Noxopharm Limited Stock Net Income
| NOXOFDelisted Stock | USD 0.04 0.00 0.00% |
In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Noxopharm Limited, as well as the relationship between them.
Noxopharm's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Noxopharm's valuation are provided below:Noxopharm Limited does not presently have any fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Noxopharm |
Search Suggestions
| N | Protective Life Dynamic | FundDelisted |
| NTRSO | Northern Trust | Company |
| NB | NioCorp Developments Ltd | Company |
| NAD | Nuveen Dividend Advantage | Fund |
| NA | Nano Labs | ETF |
| NY | NYSE 100 Index | Index |
| NXS | NXS | Cryptocurrency |
| N7163RAD5 | PRXNA 4027 03 AUG 50 | Corporate Bond |
| NGUSD | Natural Gas | Commodity |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Noxopharm Limited reported net income of (18.67 Million). This is 105.47% lower than that of the Healthcare sector and 126.65% lower than that of the Biotechnology industry. The net income for all United States stocks is 103.27% higher than that of the company.
Noxopharm Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Noxopharm's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Noxopharm could also be used in its relative valuation, which is a method of valuing Noxopharm by comparing valuation metrics of similar companies.Noxopharm is currently under evaluation in net income category among its peers.
Noxopharm Fundamentals
| Return On Equity | -0.58 | |||
| Return On Asset | -0.16 | |||
| Operating Margin | (1.80) % | |||
| Current Valuation | 22.3 M | |||
| Shares Outstanding | 292.24 M | |||
| Shares Owned By Insiders | 33.53 % | |||
| Shares Owned By Institutions | 1.00 % | |||
| Price To Book | 2.36 X | |||
| Price To Sales | 7.11 X | |||
| Revenue | 5.43 M | |||
| Gross Profit | (2.35 M) | |||
| EBITDA | (18.33 M) | |||
| Net Income | (18.67 M) | |||
| Cash And Equivalents | 14.01 M | |||
| Cash Per Share | 0.05 X | |||
| Total Debt | 160.62 K | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 9.13 X | |||
| Book Value Per Share | 0.08 X | |||
| Cash Flow From Operations | (13.73 M) | |||
| Earnings Per Share | (0.03) X | |||
| Beta | 1.25 | |||
| Market Capitalization | 38.58 M | |||
| Total Asset | 26.59 M | |||
| Net Asset | 26.59 M |
About Noxopharm Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Noxopharm Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Noxopharm using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Noxopharm Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Consideration for investing in Noxopharm Pink Sheet
If you are still planning to invest in Noxopharm Limited check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Noxopharm's history and understand the potential risks before investing.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |